UPDATE: Roth Capital Resumes Aptose Biosciences (APTO) at Buy
Tweet Send to a Friend
(Updated - October 23, 2017 7:30 AM EDT)
(updated to add analyst comment)Roth Capital resumes coverage on Aptose Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comment)Roth Capital resumes coverage on Aptose Biosciences ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
